Post-Thrombotic Syndrome: Understanding the Effects and Implementing Best Practices for Treatment
Paul J. Gagne, MD
The Vascular Experts
Kathleen Gibson, MD
Lake Washington Vascular Surgeons
Erin H. Murphy, MD, FACS
Director, Venous and Lymphatic Institute
Sanger Heart and Vascular, Atrium Health
Charlotte, North Carolina
Ronald S. Winokur, MD, FSIR, RPVI
Associate Professor of Radiology
Director of Venous Interventions
Vascular & Interventional Radiology
Provided by North American Center for Continuing Medical Education, LLC (NACCME), an HMP Company.
For questions regarding this educational activity, please call 609-371-1137 or email email@example.com.
This activity is designed for interventional radiologists, vascular surgeons, interventional cardiologists, nurses and techs
After participating in this activity, learners should be better able to:
- Understand the effects that Post-Thrombotic Syndrome (PTS) can have on a patient’s quality of life
- Identify current commercially available, and future, treatment approaches for the treatment of PTS
- Utilize stent in treatment of PTS when applicable
- Understand the post-procedural needs for a patient with PTS
To be eligible for credit, participants must complete the online activity and the evaluation. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
Release Date: December 18, 2020
Expiration Date: December 18, 2022
Estimated Time to Complete: 1.50 hours
There is no fee associated with this activity.
NACCME would like to thank the following company who has supported "Post-Thrombotic Syndrome: Understanding the Effects, and Implementing Best Practices for Treatment" through educational grants and/or in-kind support: Medtronic
In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NACCME designates this internet enduring activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 1.50 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.50 contact hours.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation.
VASCULAR & INTERVENTIONAL RADIOGRAPHERS
Post-Thrombotic Syndrome: Understanding the Effects, and Implementing Best Practices for Treatment taking place from December 18, 2020 to December 18, 2021 has been approved for 1.50 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).
USE OF PROPRIETARY NAMES
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.
The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
Peter Oettgen, MD
Beth Israel Deaconess Medical Center
Nurse Planner: Susie Seaman, NP, MSN, CWOCN, Infectious Disease Consultants/San Diego Infusion Center, San Diego, CA
In addition to the faculty listed below, NACCME planners and staff include Samantha Conforti, Mary Johnson, Randy Robbin, Greaton Sellers, Margie Stefan and Colleen Waters.
No other planner has disclosed a relevant financial relationship with any commercial interest.
The faculty has reported the following:
Dr. Gagne: Advisory Board—Boston Scientific, Cook Medical, Philips; Speakers’ Bureau—Bard, Boston Scientific, Cook Medical, Philips
Dr. Gibson: Consultant—Boston Scientific, Gore, Medtronic, Phillips, Vesper; Research—Bard, Bayer, Medtronic, Vasper
Dr. Murphy: Advisory Board—Boston Scientific, Medtronic, Philips, Vesper; Consultant—Boston Scientific, Cook, Medtronic, Philips, Vesper
Dr. Winokur: Speakers' Bureau—Penumbra; Consultant—BD/Bard, Cordis, Inari Medical, Mentice AB, Phillips Healthcare
Ms. Seaman: Speakers' Bureau—Next Science
Dr. Oettgen has disclosed no relevant financial relationships with any commercial interests.
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by NACCME, LLC may contact Samantha Conforti, Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at firstname.lastname@example.org or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Manager, Accreditation and Compliance will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Associate Director, Greaton Sellers, Accreditation and Compliance, can be requested for a second level of review. Mr. Sellers can be contacted via phone at 609-371-1137, by email at email@example.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520.